Lineage Cell Therapeutics Insider Trades

LCTX

Track insider trading activity from Lineage Cell Therapeutics executives and directors. See which insiders are buying and selling LCTX stock.

Trades Last 12 Months

LCTX Price

All Insider Trades for Lineage Cell Therapeutics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Culley Brian M President And CEO
Holding Value $307k 255,516 shares
Last Trade
Mar 12, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$24.5k 15,000 shares
$1.63
$1.20
Howe Jill Ann Chief Financial Officer
Holding Value $1.26M 1,050,000 shares
Last Trade
Mar 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.93M 1,050,000 shares
$1.84
$1.20
Samuel George A. Iii General Counsel And Secretary
Holding Value $1.08M 900,000 shares
Last Trade
Mar 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.66M 900,000 shares
$1.84
$1.20
Holding Value $90k 75,000 shares
Last Trade
Jul 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$67.5k 75,000 shares
$0.90
$1.20
Amin Dipti Director
Holding Value $90k 75,000 shares
Last Trade
Jul 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$67.5k 75,000 shares
$0.90
$1.20
Russell Angus C. Director
Holding Value $90k 75,000 shares
Last Trade
Jul 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$67.5k 75,000 shares
$0.90
$1.20
Jayasuriya Anula Director
Holding Value $90k 75,000 shares
Last Trade
Jul 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$67.5k 75,000 shares
$0.90
$1.20
Holding Value $90k 75,000 shares
Last Trade
Jul 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$67.5k 75,000 shares
$0.90
$1.20
Bradsher Neal C 10% owner
Holding Value $90k 75,000 shares
Last Trade
Jul 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$67.5k 75,000 shares
$0.90
$1.20
Holding Value $59.5M 49,560,992 shares
Last Trade
Jan 27, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$4.86M 7,894,737 shares
$0.62
$1.20
Bailey Don M Director
Holding Value $90k 75,000 shares
Last Trade
Jul 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$71.3k 75,000 shares
$0.95
$1.20
Holding Value $60k 50,000 shares
Last Trade
Jul 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$70.5k 50,000 shares
$1.41
$1.20
Hogge Gary S. Svp,clinical & Medical Affairs
Holding Value $480k 400,000 shares
Last Trade
Mar 09, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$584k 400,000 shares
$1.46
$1.20
Hernandez Alexandra Sr Director Finance/controller
Holding Value $0 0 shares
Last Trade
Jul 07, 2022 Sale
$361k 219,892 shares
$1.64
$1.20
Cook Kevin Leon Chief Financial Officer
Holding Value $780k 650,000 shares
Last Trade
Mar 10, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$910k 650,000 shares
$1.40
$1.20
Leavitt Chase C. General Counsel/secretary
Holding Value $839k 699,100 shares
Last Trade
Mar 15, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.7M 699,100 shares
$2.43
$1.20
Holding Value $48k 40,000 shares
Last Trade
Jul 01, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$33.2k 40,000 shares
$0.83
$1.20
Roberts Brandi CFO & SVP Finance
Holding Value $740k 616,700 shares
Last Trade
Mar 17, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$426k 616,700 shares
$0.69
$1.20
Patton Stephana Eilene General Counsel & Secretary
Holding Value $52.8k 43,995 shares
Last Trade
Dec 18, 2018 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$28.3k 27,500 shares
$1.03
$1.20
Skibsted Russell Chief Financial Officer
Holding Value $28.9k 24,078 shares
Last Trade
Dec 18, 2018 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$8.01k 7,781 shares
$1.03
$1.20

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up